DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Sodium fluoride f-18is the generic ingredient in three branded drugs marketed by Ge Healthcare, Nih Nci Dctd, 3d Imaging Drug, Biomedcl Res Fdn, Cardinal Health 414, Decatur, Essential Isotopes, Hot Shots Nm Llc, Houston Cyclotron, Jubilant Draximage, Kreitchman Pet Ctr, Mcprf, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Spectron Mrc Llc, The Feinstein Inst, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Tx Md Anderson, and Univ Utah Cyclotron, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.
There are one thousand four hundred and seventy-two drug master file entries for sodium fluoride f-18. Seventeen suppliers are listed for this compound.
Recent Clinical Trials for sodium fluoride f-18
Identify potential brand extensions & 505(b)(2) entrants
|Cairo University||Phase 4|
|National Institute of Dental and Craniofacial Research (NIDCR)||Phase 2|
Pharmacology for sodium fluoride f-18
|Drug Class||Radioactive Diagnostic Agent |
|Mechanism of Action||Radiopharmaceutical Activity |
Medical Subject Heading (MeSH) Categories for sodium fluoride f-18
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Ncm Usa Bronx Llc||SODIUM FLUORIDE F-18||sodium fluoride f-18||INJECTABLE;INTRAVENOUS||204513-001||Nov 28, 2014||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Mcprf||SODIUM FLUORIDE F-18||sodium fluoride f-18||INJECTABLE;INTRAVENOUS||203605-001||Jun 28, 2013||RX||No||Yes||Start Trial||Start Trial||Start Trial|
|Essential Isotopes||SODIUM FLUORIDE F-18||sodium fluoride f-18||INJECTABLE;INTRAVENOUS||204541-001||Oct 29, 2014||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Jubilant Draximage||SODIUM FLUORIDE F-18||sodium fluoride f-18||INJECTABLE;INTRAVENOUS||203968-001||Oct 23, 2015||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.